Unlocking the European Market for Your Rare Disorder Assets


Navigate the complexities of the European rare disorders market with our unmatched expertise

Strategic Advisory and Consulting

We provide tailored strategic guidance to help you develop an accelerated market entry strategy and maximize the commercial potential of your rare disorder assets.

Partnering

Our extensive industry connections enable us to identify and connect you with potential partners for licensing, co-development, and commercialization opportunities. We assist you in navigating the world of rare disorder financing, connecting you with potential investors and financing partners to accelerate your development and
commercialization efforts.

Executive and Board Search

Navigating the intricate landscape of the European rare and orphan disorders pharmaceutical and biotechnology industry demands exceptional leadership. Our unparalleled industry connections empower us to identify and recruit the most astute minds, ensuring your organization commands the expertise necessary to excel in this specialized domain.

Partner Forward: Accelerator Program

Our bespoke Accelerator Program, Partner Forward, provides the support, resources, and access to our seasoned industry leaders to fast-track your rare disorder asset development and commercialization, from early-stage innovation to successful market launch.

Discover our story

More about who we are, why we started, and what we can do for you.

Two Co Workers Having a Chat In The Office

Meet our experts

Industry’s rare disorders experts creating exceptional outcomes

Taking it forward

Accelerating Your Innovation’s Journey to Market with our bespoke Accelerator Program.

Partner Forward Logo

Taking it forward

Accelerating Your Innovation’s Journey to Market with our bespoke Accelerator Program.

Read our

latest insights

EU As A Launch Pad

EU As A Launch Pad

EU As A Launch Pad Think Global, Start European: A Strategic Launchpad for Rare Disease Therapies The global rare disease landscape is evolving rapidly, with increasing investment and a growing pipeline of…

Bringing Cell Therapies to Rare Disease Patients in Europe

Bringing Cell Therapies to Rare Disease Patients in Europe

Bringing Cell Therapies to Rare Disease Patients in Europe Rare diseases are defined by sheer numbers of new patients per population. This definition is not helpful for the affected patient and his/her…